News (Media Awareness Project) - UK: Web: Cannabis 'Reduces Surgery Pain' |
Title: | UK: Web: Cannabis 'Reduces Surgery Pain' |
Published On: | 2006-06-02 |
Source: | BBC News (UK Web) |
Fetched On: | 2008-01-14 03:25:01 |
CANNABIS 'REDUCES SURGERY PAIN'
A cannabis plant extract provides pain relief for patients after
major surgery, research has shown.
An Imperial College London team tested the extract - Cannador - on 65
patients after surgery such as knee replacements and found it helped
manage pain.
The researchers believe the results could lead to new pain relief
drugs, even though the chance of side effects increased with stronger doses.
The research appears in the US journal Anesthesiology.
Lead researcher Dr Anita Holdcroft said: "Pain after surgery
continues to be a problem because many of the commonly used drugs are
either ineffective or have too many side effects.
"These results show that cannabinoids are effective and may lead to
the development of a wider range of drugs to manage post-operative pain."
The researchers tested Cannador in different doses on 65 patients who
had previously undergone surgery.
While all 11 patients who received a 5mg dose of the drug requested
additional pain relief, only 15 of the 30 who received the 10mg dose
and 6 of the 24 on the 15mg dose did so.
Side Effects
However as the dose increased some patients reported increased side
effects such as nausea and increased heart rate.
Professor Mervyn Maze from Imperial College London, who also worked
on the study, said: "We thought cannabis might be beneficial in
helping manage pain following surgery, as previous research indicated
cannabinoids help 'top up' the body's natural system for reducing
pain sensation.
"This research proves it can be effective, with minimal side effects
at low doses."
GW Pharmaceuticals, a Salisbury-based firm, is developing
cannabis-based medicines under licence from the UK government.
One of its products, Sativex, has already been licensed in Canada for
pain control in people with multiple sclerosis, and trials of the
drug's ability to provide pain relief for people with advanced cancer
are continuing.
Mark Rogerson, a company spokesman, said: "This latest trial is
another welcome contribution to the body of evidence that
cannabinoids have a role to play in medicine."
A cannabis plant extract provides pain relief for patients after
major surgery, research has shown.
An Imperial College London team tested the extract - Cannador - on 65
patients after surgery such as knee replacements and found it helped
manage pain.
The researchers believe the results could lead to new pain relief
drugs, even though the chance of side effects increased with stronger doses.
The research appears in the US journal Anesthesiology.
Lead researcher Dr Anita Holdcroft said: "Pain after surgery
continues to be a problem because many of the commonly used drugs are
either ineffective or have too many side effects.
"These results show that cannabinoids are effective and may lead to
the development of a wider range of drugs to manage post-operative pain."
The researchers tested Cannador in different doses on 65 patients who
had previously undergone surgery.
While all 11 patients who received a 5mg dose of the drug requested
additional pain relief, only 15 of the 30 who received the 10mg dose
and 6 of the 24 on the 15mg dose did so.
Side Effects
However as the dose increased some patients reported increased side
effects such as nausea and increased heart rate.
Professor Mervyn Maze from Imperial College London, who also worked
on the study, said: "We thought cannabis might be beneficial in
helping manage pain following surgery, as previous research indicated
cannabinoids help 'top up' the body's natural system for reducing
pain sensation.
"This research proves it can be effective, with minimal side effects
at low doses."
GW Pharmaceuticals, a Salisbury-based firm, is developing
cannabis-based medicines under licence from the UK government.
One of its products, Sativex, has already been licensed in Canada for
pain control in people with multiple sclerosis, and trials of the
drug's ability to provide pain relief for people with advanced cancer
are continuing.
Mark Rogerson, a company spokesman, said: "This latest trial is
another welcome contribution to the body of evidence that
cannabinoids have a role to play in medicine."
Member Comments |
No member comments available...